Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil for Erectile Dysfunction and Portal Hemodynamics in Liver Cirrhosis
NCT02344823Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- Jun 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) and Portal Hypertension (PH), sponsored by Medical University of Vienna. Primary endpoint: Hepatic Venous Pressure Gradient at 7 days. Status: unknown.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT02344823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344823.